COMPARE · Data as of August 21, 2026

CON vs DVA

Verdict: Side-by-side breakdown using the Bull Rankings model. CON scored 69.3, DVA scored 68.9 — CON leads.
Compare another set
CON
Concentra Group Holdings Parent, Inc.
Medical Care Facilities · Quality-Growth
69.3
$35.00 · $4.5B
fundamentals as of
Score gap
0.4
CON leads
DVA
DaVita Inc.
Medical Care Facilities · Quality-Growth
68.9
$173.82 · $11.1B
fundamentals as of
  • CheapestDVA14.7x
  • Fastest growthCON+14.0%
  • Highest qualityCON74 / 100
  • Largest discount to fair valueDVA-67%
THE BULL RANKINGS SCORECARD69.3/ 100 · BULL SCOREPEER MEDIANQUALITY74.0GROWTH82.2VALUE54.6
THE BULL RANKINGS SCORECARD68.9/ 100 · BULL SCOREPEER MEDIANQUALITY68.9GROWTH67.8VALUE69.9
CONDVAQuality74.068.9Growth82.267.8Value54.669.9
cheap & fastrevenue growth →← cheaper (lower multiple)-4%24%9.7x28xCONDVA

Growth against the P/E multiple. Up and to the right is cheaper and faster — the quality-growth idea in one picture. Points beyond the axis are pinned to the edge and marked off-scale rather than allowed to compress everything else.

FCFCON$267mDVA$1.6b
RevCON+14.0%DVA+6.4%
P/ECON22.6xDVA14.7x
PEGCON1.94DVA0.55
CON
stronger →← stronger
DVA
74
Qualityreturns · margins · balance sheet
69
82
Growthrevenue & earnings expansion
68
55
Valuevaluation vs sector peers
70
CON is stronger on 2 of 3 pillars.
CON
DVA
$267mC
FCF
$1.6bC+
+14.0%B+
Rev
+6.4%C+
4.23D
D/E
22.6xB+
P/E
14.7xA-
1.94C+
PEG
0.55A-
Winner per row is the stronger grade; where grades tie, the better figure breaks it. A true tie or a missing value shows no highlight.
CON
DVA
35% below
Price vs fair valuelower is cheaper
67% below
~-2%/yr
Growth the price implies10-yr FCF · lower = less priced in
~-17%/yr
+37%
1-yr DCF upside
+165%
+53%
5-yr DCF upside
+207%
+81%
10-yr DCF upside
+282%
The DCF is a cross-check on intrinsic value, separate from the quality-growth score above.
CON
Why this score
  • Durable high returns
  • Short track record
DVA
Why this score
  • Buying back stock
  • Durable high returns
CONConcentra Group Holdings Parent, Inc.
Medical Care Facilities · $35.00 · beta 0.62
Why now
Medical Care Facilities · market cap $4.5b. Trading near 52-week high of $35.90 — momentum setup, limited technical margin of safety. Revenue growing +14%, comfortably above the S&P median. 8 sell-side analysts rate this a Strong Buy with a mean 1-yr target of $39.88 (implying +14% upside).
Moat
ROE 42% — top-decile capital efficiency. Either pricing leverage, low capital intensity, or aggressive buybacks; the durability story depends on which. FCF converts 135% of net income — earnings translate cleanly into cash, a sign that working capital and capex are well-disciplined.
Risk
D/E 4.23 is elevated — limits strategic flexibility and raises refinancing exposure if rates stay higher for longer. Trading within 3% of the 52-week high — limited technical margin of safety; a momentum reversal would test conviction.
DVADaVita Inc.
Medical Care Facilities · $173.82 · beta 0.87
Why now
Medical Care Facilities · market cap $11.1b. Down 30% from 52-week high of $247.49 — deep drawdown territory. PEG 0.55 — paying under fair value for the growth rate. 7 sell-side analysts rate this a Buy with a mean 1-yr target of $218.43 (implying +26% upside).
Moat
FCF converts 136% of net income — earnings translate cleanly into cash, a sign that working capital and capex are well-disciplined.
Risk
ROE -154% is below the long-run sustainable threshold of ~10% — capital efficiency would need to improve for the equity base to compound at the market rate.
Generating verdict… typically 5–10 seconds
Not investment advice. The Bull Rankings publishes a quantitative ranking model and accompanying analysis for general informational purposes only. Nothing on this page is a recommendation to buy, sell, or hold any security; nothing is personalized to your circumstances, risk tolerance, or tax situation. Investing carries the risk of loss — invest at your own risk and consider consulting a licensed financial professional before acting on anything you read here. See terms and methodology for full disclosures.

Where CON and DVA diverge

The two are effectively level on the headline score. They get there differently, though — each leads on a different pillar, so the better pick depends on which you weight.

Pillars run 0–100 against sector peers, so a score is a statement about a company relative to its own industry rather than to the other name here. A wide Value gap usually means the market already prices the difference in quality or growth — which is the trade-off this comparison comes down to.